Trademark: 88929298
Word
BASETAG
Status
Dead
Status Code
606
Status Date
Monday, December 18, 2023
Serial Number
88929298
Mark Type
4000
Filing Date
Friday, May 22, 2020
Published for Opposition
Tuesday, September 15, 2020
Abandoned Date
Monday, December 18, 2023

Trademark Owner History
Roche Molecular Systems, Inc. - Owner At Publication

Classifications
9 Scientific and laboratory apparatus, devices and instruments for identifying, sequencing, analyzing, measuring and recording dna or other molecules for non-medical purposes, namely, genome sequencers; laboratory instruments, namely, devices for analysis of nucleic acids, namely, nucleic acid analyzers; laboratory apparatus, namely, nucleic acid sequencers; computer systems and downloadable software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes; downloadable computer software for use in analyzing, managing and visualizing dna sequencing data; laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; automated laboratory apparatus and systems, namely, sample loaders and bar code readers and downloadable operating software sold as a unit for use in laboratory operations
5 In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis
1 In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing dna, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with dna sequencing and genetic analysis
44 Medical services for analysis of genetics; genetic testing for medical purposes; nucleic acid based testing for medical purposes; medical services in the field of nucleic acid analysis; medical services in the field of genetic screening
10 Apparatus, devices and instruments for identifying, sequencing, analyzing, measuring and recording dna or other molecules for medical diagnostics purposes, namely, genome sequencers; medical diagnostic and analytical apparatus for medical diagnostic purposes; medical equipment, namely, devices for analyzing nucleic acids and for dna sequencing for the purpose of rendering medical treatment and diagnosis, namely, nucleic acid analyzers and nucleic acid sequencers
42 Scientific research and consultancy services related thereto in the fields of genome sequence analysis and reporting; medical research services in the fields of genome sequence analysis and reporting; providing dna screening for scientific research purposes; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory instruments and computer systems for use in science and clinical research; consultancy, information and advisory services in the field of analysis of biomolecules as it relates to dna screening and genome sequence analysis and reporting
BASE TAG

Trademark Events
Dec 18, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 18, 2023
Abandonment - No Use Statement Filed
May 10, 2023
Notice Of Approval Of Extension Request E-Mailed
May 9, 2023
Sou Extension 5 Granted
May 3, 2023
Sou Extension 5 Filed
May 8, 2023
Case Assigned To Intent To Use Paralegal
May 3, 2023
Sou Teas Extension Received
Nov 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2022
Sou Extension 4 Granted
Nov 7, 2022
Sou Extension 4 Filed
Nov 7, 2022
Sou Teas Extension Received
Apr 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2022
Sou Extension 3 Granted
Apr 12, 2022
Sou Extension 3 Filed
Apr 12, 2022
Sou Teas Extension Received
Nov 4, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2021
Sou Extension 2 Granted
Nov 2, 2021
Sou Extension 2 Filed
Nov 2, 2021
Sou Teas Extension Received
Apr 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 19, 2021
Sou Extension 1 Granted
Apr 19, 2021
Sou Extension 1 Filed
Apr 19, 2021
Sou Teas Extension Received
Nov 10, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 19, 2020
Teas Change Of Correspondence Received
Oct 19, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 19, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 19, 2020
Teas Change Of Owner Address Received
Sep 15, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 15, 2020
Published For Opposition
Aug 26, 2020
Notification Of Notice Of Publication E-Mailed
Aug 6, 2020
Approved For Pub - Principal Register
Aug 6, 2020
Examiner's Amendment Entered
Aug 6, 2020
Notification Of Examiners Amendment E-Mailed
Aug 6, 2020
Examiners Amendment E-Mailed
Aug 6, 2020
Examiners Amendment -Written
Aug 5, 2020
Notification Of Non-Final Action E-Mailed
Aug 5, 2020
Non-Final Action E-Mailed
Aug 5, 2020
Non-Final Action Written
Aug 5, 2020
Previous Allowance Count Withdrawn
Aug 4, 2020
Withdrawn From Pub - Og Review Query
Jul 23, 2020
Approved For Pub - Principal Register
Jul 22, 2020
Teas/Email Correspondence Entered
Jul 22, 2020
Correspondence Received In Law Office
Jul 22, 2020
Teas Response To Office Action Received
Jul 20, 2020
Notification Of Non-Final Action E-Mailed
Jul 20, 2020
Non-Final Action E-Mailed
Jul 20, 2020
Non-Final Action Written
Jul 16, 2020
Assigned To Examiner
Jun 9, 2020
New Application Office Supplied Data Entered
May 26, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24